Posted inMarket Kymera Therapeutics Chief Legal Officer Executes $744K Stock Sale Discover recent insider trading activity at Kymera Therapeutics as Chief Legal Officer Adams disposes of $744k in KYMR stock. Posted by Prasenjit Bhowmik October 15, 2026
